{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:20:37Z","timestamp":1741839637040,"version":"3.38.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-025-02114-7","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:56:31Z","timestamp":1741794991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic dysregulation with treatment response in rectal cancer patients undergoing chemoradiotherapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Qiliang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"3","key":"2114_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3322\/caac.21772","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233\u201354.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2114_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","volume":"389","author":"D Schrag","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, Gollub MJ, Saltz LB, Musher BL, et al. Preoperative treatment of locally advanced rectal Cancer. N Engl J Med. 2023;389(4):322\u201334.","journal-title":"N Engl J Med"},{"issue":"15","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C, Jiang LM, Jiang J, Li N, et al. Multicenter, randomized, phase III trial of Short-Term radiotherapy plus chemotherapy versus Long-Term chemoradiotherapy in locally advanced rectal Cancer (STELLAR). J Clin Oncol. 2022;40(15):1681\u201392.","journal-title":"J Clin Oncol"},{"issue":"10","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/14737140.2022.2114457","volume":"22","author":"TT Pham","year":"2022","unstructured":"Pham TT, Lim S, Lin M. Predicting neoadjuvant chemoradiotherapy response with functional imaging and liquid biomarkers in locally advanced rectal cancer. Expert Rev Anticancer Ther. 2022;22(10):1081\u201398.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3322\/caac.21670","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt DR, Patel R, Kirsch DG, Lewis CA, Vander Heiden MG, Locasale JW. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021;71(4):333\u201358.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2114_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12859-023-05383-0","volume":"24","author":"NR Anwardeen","year":"2023","unstructured":"Anwardeen NR, Diboun I, Mokrab Y, Althani AA, Elrayess MA. Statistical methods and resources for biomarker discovery using metabolomics. BMC Bioinformatics. 2023;24(1):250.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"2114_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11306-022-01959-8","volume":"18","author":"J Lv","year":"2022","unstructured":"Lv J, Jia H, Mo M, Yuan J, Wu Z, Zhang S, et al. Changes of serum metabolites levels during neoadjuvant chemoradiation and prediction of the pathological response in locally advanced rectal cancer. Metabolomics. 2022;18(12):99.","journal-title":"Metabolomics"},{"issue":"3","key":"2114_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.radonc.2018.06.022","volume":"128","author":"H Jia","year":"2018","unstructured":"Jia H, Shen X, Guan Y, Xu M, Tu J, Mo M, et al. Predicting the pathological response to neoadjuvant chemoradiation using untargeted metabolomics in locally advanced rectal cancer. Radiother Oncol. 2018;128(3):548\u201356.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1038\/s41467-022-35511-y","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Jia H, Gao Y, Zhang H, Fan J, Zhang L, et al. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer. Nat Commun. 2022;13(1):7802.","journal-title":"Nat Commun"},{"issue":"11","key":"2114_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11306-018-1449-2","volume":"14","author":"DJ Beale","year":"2018","unstructured":"Beale DJ, Pinu FR, Kouremenos KA, Poojary MM, Narayana VK, Boughton BA, et al. Review of recent developments in GC-MS approaches to metabolomics-based research. Metabolomics. 2018;14(11):152.","journal-title":"Metabolomics"},{"key":"2114_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpba.2017.07.013","volume":"147","author":"G Lubes","year":"2018","unstructured":"Lubes G, Goodarzi M. GC-MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers. J Pharm Biomed Anal. 2018;147:313\u201322.","journal-title":"J Pharm Biomed Anal"},{"key":"2114_CR12","doi-asserted-by":"crossref","unstructured":"Kiseleva O, Kurbatov I, Ilgisonis E, Poverennaya E. Defining blood plasma and serum metabolome by GC-MS. Metabolites 2021;12(1).","DOI":"10.3390\/metabo12010015"},{"key":"2114_CR13","doi-asserted-by":"crossref","unstructured":"Ueta I, Sumiya K, Fujimura K, Ariizumi Y, Kikuchi R, Kawata K et al. Volatile anticancer drug determination by thermal desorption technique with polydimethylsiloxane-coated macroporous silica adsorbent in gas chromatography-mass spectrometry. Anal Sci 2023.","DOI":"10.1016\/j.jcoa.2023.100084"},{"issue":"36","key":"2114_CR14","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1200\/JCO.20.01932","volume":"38","author":"J Zhu","year":"2020","unstructured":"Zhu J, Liu A, Sun X, Liu L, Zhu Y, Zhang T, et al. Multicenter, randomized, phase III trial of neoadjuvant chemoradiation with capecitabine and Irinotecan guided by UGT1A1 status in patients with locally advanced rectal Cancer. J Clin Oncol. 2020;38(36):4231\u20139.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2114_CR15","doi-asserted-by":"publisher","first-page":"e780","DOI":"10.1002\/onco.13707","volume":"26","author":"HY Chen","year":"2021","unstructured":"Chen HY, Feng LL, Li M, Ju HQ, Ding Y, Lan M, et al. College of American pathologists tumor regression grading system for Long-Term outcome in patients with locally advanced rectal Cancer. Oncologist. 2021;26(5):e780\u201393.","journal-title":"Oncologist"},{"issue":"6","key":"2114_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, et al. MS-DIAL: data-independent MS\/MS Deconvolution for comprehensive metabolome analysis. Nat Methods. 2015;12(6):523\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-anchem-061318-115314","volume":"13","author":"SJ Choquette","year":"2020","unstructured":"Choquette SJ, Duewer DL, Sharpless KE. NIST reference materials: utility and future. Annu Rev Anal Chem (Palo Alto Calif). 2020;13(1):453\u201374.","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"2114_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fbioe.2015.00023","volume":"3","author":"A Alonso","year":"2015","unstructured":"Alonso A, Marsal S, Julia A. Analytical methods in untargeted metabolomics: state of the Art in 2015. Front Bioeng Biotechnol. 2015;3:23.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"2114_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10238-022-00931-z","volume":"23","author":"B Chen","year":"2023","unstructured":"Chen B, Wang Y, Wang Q, Li D, Huang X, Kuang X, et al. Untargeted metabolomics identifies potential serum biomarkers associated with Crohn\u2019s disease. Clin Exp Med. 2023;23(5):1751\u201361.","journal-title":"Clin Exp Med"},{"key":"2114_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.aca.2013.01.022","volume":"769","author":"J Boccard","year":"2013","unstructured":"Boccard J, Rutledge DN. A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock omics data fusion. Anal Chim Acta. 2013;769:30\u20139.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","volume":"2","author":"L Kumar","year":"2007","unstructured":"Kumar L. Mfuzz: a software package for soft clustering of microarray data. Bioinformation. 2007;2(1):5\u20137.","journal-title":"Bioinformation"},{"issue":"D1","key":"2114_CR22","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2021;49(D1):D545\u201351.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2114_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/med.21658","volume":"40","author":"S Basith","year":"2020","unstructured":"Basith S, Manavalan B, Hwan Shin T, Lee G. Machine intelligence in peptide therapeutics: A next-generation tool for rapid disease screening. Med Res Rev. 2020;40(4):1276\u2013314.","journal-title":"Med Res Rev"},{"issue":"2","key":"2114_CR24","first-page":"627","volume":"4","author":"K Hajian-Tilaki","year":"2013","unstructured":"Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med. 2013;4(2):627\u201335.","journal-title":"Casp J Intern Med"},{"key":"2114_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12859-016-0900-5","volume":"17","author":"H Wang","year":"2016","unstructured":"Wang H, Yang F, Luo Z. An experimental study of the intrinsic stability of random forest variable importance measures. BMC Bioinformatics. 2016;17:60.","journal-title":"BMC Bioinformatics"},{"key":"2114_CR26","doi-asserted-by":"publisher","first-page":"1482927","DOI":"10.3389\/fgene.2024.1482927","volume":"15","author":"Y Jing","year":"2024","unstructured":"Jing Y, Huang X, Wang Y, Wang J, Li Y, Yelihamu D, et al. Diagnostic value of 5 MiRNAs combined detection for breast cancer. Front Genet. 2024;15:1482927.","journal-title":"Front Genet"},{"issue":"7","key":"2114_CR27","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.21037\/tcr-23-34","volume":"12","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wang Y, Bi X, Ismtula D, Wang H, Guo C. Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer. Transl Cancer Res. 2023;12(7):1765\u201386.","journal-title":"Transl Cancer Res"},{"key":"2114_CR28","doi-asserted-by":"publisher","first-page":"101828","DOI":"10.1016\/j.tranon.2023.101828","volume":"39","author":"Q Peng","year":"2024","unstructured":"Peng Q, Tao J, Xu Y, Shen Y, Wang Y, Jiao Y, et al. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. Transl Oncol. 2024;39:101828.","journal-title":"Transl Oncol"},{"issue":"12","key":"2114_CR29","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1007\/s12094-024-03537-x","volume":"26","author":"Q Peng","year":"2024","unstructured":"Peng Q, Jiang L, Shen Y, Xu Y, Shen X, Zou L, et al. LC-MS metabolomics analysis of serum metabolites during neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Clin Transl Oncol. 2024;26(12):3150\u201368.","journal-title":"Clin Transl Oncol"},{"issue":"2\u20133","key":"2114_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10555-018-9742-0","volume":"37","author":"W Kim","year":"2018","unstructured":"Kim W, Son B, Lee S, Do H, Youn B. Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy. Cancer Metastasis Rev. 2018;37(2\u20133):213\u201325.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"2114_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41420-023-01645-1","volume":"9","author":"X Chen","year":"2023","unstructured":"Chen X, Zhang L, He Y, Huang S, Chen S, Zhao W, et al. Regulation of m(6)A modification on ferroptosis and its potential significance in radiosensitization. Cell Death Discov. 2023;9(1):343.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2114_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, Jin X, Ye F, Liu X, Yu B, Li Z, et al. Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy. Exp Hematol Oncol. 2023;12(1):65.","journal-title":"Exp Hematol Oncol"},{"key":"2114_CR33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biochi.2021.02.008","volume":"184","author":"YF Liang","year":"2021","unstructured":"Liang YF, Long ZX, Zhang YJ, Luo CY, Yan LT, Gao WY, et al. The chemical mechanisms of the enzymes in the branched-chain amino acids biosynthetic pathway and their applications. Biochimie. 2021;184:72\u201387.","journal-title":"Biochimie"},{"issue":"44","key":"2114_CR34","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1038\/s41388-020-01480-z","volume":"39","author":"H Peng","year":"2020","unstructured":"Peng H, Wang Y, Luo W. Multifaceted role of branched-chain amino acid metabolism in cancer. Oncogene. 2020;39(44):6747\u201356.","journal-title":"Oncogene"},{"issue":"11","key":"2114_CR35","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/1078-0432.CCR-20-3913","volume":"27","author":"DF Boreel","year":"2021","unstructured":"Boreel DF, Span PN, Heskamp S, Adema GJ, Bussink J. Targeting oxidative phosphorylation to increase the efficacy of Radio- and Immune-Combination therapy. Clin Cancer Res. 2021;27(11):2970\u20138.","journal-title":"Clin Cancer Res"},{"key":"2114_CR36","doi-asserted-by":"crossref","unstructured":"Chen D, Barsoumian HB, Fischer G, Yang L, Verma V, Younes AI et al. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity. J Immunother Cancer 2020;8(1).","DOI":"10.1136\/jitc-2019-000289"},{"key":"2114_CR37","doi-asserted-by":"publisher","first-page":"4013575","DOI":"10.1155\/2022\/4013575","volume":"2022","author":"S Wu","year":"2022","unstructured":"Wu S, Liu X, Cheng L, Wang D, Qin G, Zhang X, et al. Protective mechanism of leucine and isoleucine against H(2)O(2)-Induced oxidative damage in bovine mammary epithelial cells. Oxid Med Cell Longev. 2022;2022:4013575.","journal-title":"Oxid Med Cell Longev"},{"issue":"27","key":"2114_CR38","doi-asserted-by":"publisher","first-page":"44893","DOI":"10.18632\/oncotarget.16488","volume":"8","author":"Q Peng","year":"2017","unstructured":"Peng Q, Zhang X, Min M, Zou L, Shen P, Zhu Y. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(27):44893\u2013909.","journal-title":"Oncotarget"},{"issue":"1","key":"2114_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12967-018-1510-y","volume":"16","author":"Q Peng","year":"2018","unstructured":"Peng Q, Shen Y, Lin K, Zou L, Shen Y, Zhu Y. Comprehensive and integrative analysis identifies microRNA-106 as a novel non-invasive biomarker for detection of gastric cancer. J Transl Med. 2018;16(1):127.","journal-title":"J Transl Med"},{"key":"2114_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12935-019-0907-x","volume":"19","author":"Q Peng","year":"2019","unstructured":"Peng Q, Feng Z, Shen Y, Zhu J, Zou L, Shen Y, et al. Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer. Cancer Cell Int. 2019;19:181.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2114_CR41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1186\/s12885-024-13265-8","volume":"24","author":"Q Peng","year":"2024","unstructured":"Peng Q, Zhan C, Shen Y, Xu Y, Ren B, Feng Z, et al. Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patients. BMC Cancer. 2024;24(1):1549.","journal-title":"BMC Cancer"},{"key":"2114_CR42","doi-asserted-by":"publisher","first-page":"1050721","DOI":"10.3389\/fimmu.2022.1050721","volume":"13","author":"H Zhou","year":"2022","unstructured":"Zhou H, Chen Y, Xiao Y, Wu Q, Li H, Li Y, et al. Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer. Front Immunol. 2022;13:1050721.","journal-title":"Front Immunol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02114-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02114-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T15:56:34Z","timestamp":1741794994000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-025-02114-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02114-7","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Second Affiliated Hospital of Soochow University and was conducted under the Declaration of Helsinki ethical principles for medical research involving human subjects. Informed consent was obtained from the children\u2019s parents. All participants provided both written and verbal consent to be part of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}